BioAdaptives, Inc.
BDPT
$0.0006
$0.000120.00%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -848.06% | 95.26% | 35.70% | 21.77% | 86.79% |
| Total Depreciation and Amortization | -1,642.86% | 735.56% | -97.06% | -97.89% | -98.32% |
| Total Amortization of Deferred Charges | -65.13% | -87.88% | -32.05% | 131.03% | -34.18% |
| Total Other Non-Cash Items | 289.16% | -190.56% | 35,600.00% | 33.35% | 5.84% |
| Change in Net Operating Assets | -165.42% | -50.54% | -86.00% | -89.52% | -90.51% |
| Cash from Operations | -232.00% | 8.78% | 26.20% | 68.14% | 22.32% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -633.23% | 495.90% | 21.33% | -- | -35.77% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 359.29% | 38.51% | -- | -35.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,647.46% | 549.80% | 402.65% | 28.04% | -64.46% |
